Stock screenerAll disclosures →
EDGAR →
VNDA
Conviction 12HealthcareScan · Fri, Jun 26, 2026VNDA$5.99+2.39%
ResistanceSupportVol 14Vol MA14 944.26K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price5.99
Change+2.39%
Gap+0.43%
Rel volume0.99×
Avg volume904.81K
Avg $ vol5.43M
SMA 206.02
SMA 506.41
SMA 2006.43
Price vs 50-6.59%
Price vs 200-6.80%
MA stackbearish
50/200 crossdeath · 0d
Supertrenddown · 6.59
RSI (14)46
MACD hist0.03
MACD crossbull · 4d
Stoch %K / %D57 / 43
ADX (14)10
+DI / −DI16 / 18
RSI divergence—
MACD divergence—
ATR %+4.40%
ADR %4.15%
52w high9.56
52w low4.19
From 52w high-37.34%
Above 52w low+42.96%
New 52w highNo
SqueezeOn · 1d
Bollinger width11.74%
%B0.46
Donchian pos36.54%
Donchian high6.65
Donchian low5.61
AVWAP (52w high)7.12
vs AVWAP high-15.83%
AVWAP (52w low)7.15
vs AVWAP low-16.27%
OBV trendDown
Chaikin MF (20)-0.27
Today vs 20d0.99×
Avg vol (14d)944.26K
Avg vol (20d)904.81K
Avg $ vol (20d)5.43M
Market cap—
RS 3m (vs SPY)-31.11%
RS 6m (vs SPY)-24.01%
RS line new highNo
Trend template3/8
Technical rank24.9
1 week+3.28%
1 month-7.28%
3 months-15.87%
6 months-12.43%
1 year+29.93%
YTD-27.39%
P/E-1.59
P/B1.25
P/S1.63
P/FCF-3.18
EPS-3.74
Div yield—
ROE-78.53%
ROA-50.86%
Debt/Eq—
Current2.16
EV/EBITDA-1.97
Gross margin28.17%
Net margin-102.02%
Rev growth8.72%
EPS growth-1066.53%
Price target19.50
Target upside233.62%
Analyst ratingBuy
Institutional85.13%
Ent. value297.46M
Revenue51.72M
Net income-48.57M
Gross profit—
Free cash flow-110.44M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.14M
Employees533
ListedWed, Apr 12, 2006
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction12 / 100
Pattern quality—
Tech rank24.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.23
Support5.77
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VNDA
No recent disclosed trades by Congress in VNDA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VNDA · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mitchell Stephen Ray Director · Common Stock · 2026-06-04 | Grant | 41.6K | $0 | 2026-06-04 | 2026-06-08 |
Chrousos Phaedra Director · Common Stock · 2026-06-04 | Grant | 41.6K | $0 | 2026-06-04 | 2026-06-08 |
Ward Anne Sempowski Director · Common Stock · 2026-06-04 | Grant | 41.6K | $0 | 2026-06-04 | 2026-06-08 |
Honore Tage Director · Common Stock · 2026-06-04 | Grant | 41.6K | $0 | 2026-06-04 | 2026-06-08 |
DUGAN RICHARD W Director · Common Stock · 2026-06-04 | Grant | 41.6K | $0 | 2026-06-04 | 2026-06-08 |
Duncan Charles Cliff Director · Common Stock · 2026-06-04 | Grant | 41.6K | $0 | 2026-06-04 | 2026-06-08 |
McGuire Daniel Patrick SVP, GC and Secretary · Common Stock · 2026-06-04 | Grant | 80K | $0 | 2026-06-04 | 2026-06-08 |
Mitchell Stephen Ray Director · Common Stock · 2026-05-18 | Gift | 25.84K | $0 | 2026-05-18 | 2026-05-20 |
Duncan Charles Cliff Director · Common Stock · 2026-04-22 | Grant | 57.1K | $0 | 2026-04-22 | 2026-04-24 |
SEC filings
EDGAR filings in VNDA · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.